All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
How Ireland became dependent on big pharma — and the risks ahead
In just 50 years, Ireland has become the world’s third largest exporter of pharmaceuticals, with medicines now making…
Common Antidepressant May Reduce Long COVID Fatigue
A clinical trial found that fluvoxamine significantly improved fatigue and quality of life for Long COVID patients with…
Health care giants are trimming jobs, not driving employment growth
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
ADHD medication in short supply in Japan as demand soars
Since last fall, Concerta, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been in short…
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medication
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
Pharma penalties for doctors’ kickbacks just a cost of doing business
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs…
Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
Europe’s healthcare – A right or a business model? MEPs face off in The Ring
Published on 18/03/2026 – 21:30 GMT+1 Did you know that the price of a pill and the waiting…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…